RBC Lifts Price Target on ResMed to $247 From $244 Amid MEDIFOX DAN Deal, Maintains Outperform Rating

06/15/2022 | 08:18am

This article is reserved for subscribers A "one-stop shopping" service for investors The best opportunities, portfolios, and screeners Discover